Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Reply by Authors.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A; SIB International Consortium.

J Urol. 2019 Nov 27:101097JU000000000000059102. doi: 10.1097/JU.0000000000000591.02. [Epub ahead of print] No abstract available.

PMID:
31774733
2.

Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer.

Agrawal S, Haas NB, Bagheri M, Lane BR, Coleman J, Hammers H, Bratslavsky G, Chauhan C, Kim L, Krishnasamy VP, Marko J, Maher VE, Ibrahim A, Cross F Jr, Liu K, Beaver JA, Pazdur R, Blumenthal GM, Singh H, Plimack ER, Choueiri TK, Uzzo R, Apolo AB.

JAMA Oncol. 2019 Nov 21. doi: 10.1001/jamaoncol.2019.4117. [Epub ahead of print]

PMID:
31750870
3.

Pelvic lymph node dissection at robot-assisted radical prostatectomy: Assessing utilization and nodal metastases within a statewide quality improvement consortium.

Lescay H, Abdollah F, Cher ML, Qi J, Linsell S, Miller DC, Montie JE, Peabody J, Kaffenberger S, Morgan T, Loeb A, Lane BR; Michigan Urological Surgery Improvement Collaborative.

Urol Oncol. 2019 Nov 15. pii: S1078-1439(19)30377-1. doi: 10.1016/j.urolonc.2019.09.026. [Epub ahead of print]

PMID:
31740331
4.

Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A; SIB International Consortium.

J Urol. 2019 Oct 14:101097JU0000000000000591. doi: 10.1097/JU.0000000000000591. [Epub ahead of print]

PMID:
31609167
5.

Palpable Abdominal Mass is a Renal Oncocytoma: Not All Large Renal Masses are Malignant.

Dey S, Noyes SL, Uddin G, Lane BR.

Case Rep Urol. 2019 Aug 8;2019:6016870. doi: 10.1155/2019/6016870. eCollection 2019.

6.

Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative.

Kirmiz SW, Babitz S, Linsell S, Qi J, Brede CM, Miller DC, Montie JE, Lane BR; Michigan Urological Surgery Improvement Collaborative.

Prostate Cancer Prostatic Dis. 2019 Aug 29. doi: 10.1038/s41391-019-0170-1. [Epub ahead of print]

PMID:
31467391
7.

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.

Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR.

Prostate Cancer Prostatic Dis. 2019 Aug 27. doi: 10.1038/s41391-019-0167-9. [Epub ahead of print]

PMID:
31455846
8.

Proteinuria impacts patient survival differentially based on clinical setting: A retrospective cross-sectional analysis of cohorts from a single health system: Retrospective cohort study.

Bezinque A, Parker J, Babitz SK, Noyes SL, Hu S, Lane BR.

Ann Med Surg (Lond). 2019 Aug 1;45:120-126. doi: 10.1016/j.amsu.2019.07.029. eCollection 2019 Sep.

9.

Sex specific associations in genome wide association analysis of renal cell carcinoma.

Laskar RS, Muller DC, Li P, Machiela MJ, Ye Y, Gaborieau V, Foll M, Hofmann JN, Colli L, Sampson JN, Wang Z, Bacq-Daian D, Boland A, Abedi-Ardekani B, Durand G, Le Calvez-Kelm F, Robinot N, Blanche H, Prokhortchouk E, Skryabin KG, Burdett L, Yeager M, Radojevic-Skodric S, Savic S, Foretova L, Holcatova I, Janout V, Mates D, Rascu S, Mukeria A, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Świątkowska B, Benhamou S, Cancel-Tassin G, Cussenot O, Trichopoulou A, Riboli E, Overvad K, Panico S, Ljungberg B, Sitaram RT, Giles GG, Milne RL, Severi G, Bruinsma F, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Beane Freeman LE, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Chow WH, Moore LE, Choueiri TK, Wood C, Johansson M, McKay JD, Brown KM, Rothman N, Lathrop MG, Deleuze JF, Wu X, Brennan P, Chanock SJ, Purdue MP, Scelo G.

Eur J Hum Genet. 2019 Oct;27(10):1589-1598. doi: 10.1038/s41431-019-0455-9. Epub 2019 Jun 23.

PMID:
31231134
10.

Using the Event Analysis of Systemic Teamwork (EAST) broken-links approach to understand vulnerabilities to disruption in a darknet market.

Lane BR, Salmon PM, Cherney A, Lacey D, Stanton NA.

Ergonomics. 2019 Sep;62(9):1134-1149. doi: 10.1080/00140139.2019.1621392. Epub 2019 Jun 3.

PMID:
31117925
11.

Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.

Field CA, Cotta BH, Jimenez J, Lane BR, Yim K, Lee HJ, Ryan ST, Hamilton ZA, Patel S, Wang S, Kane CJ, Dey S, Mckay RR, Noyes S, Millard FE, Rini BI, Campbell SC, Derweesh IH.

Clin Genitourin Cancer. 2019 Jun;17(3):e505-e512. doi: 10.1016/j.clgc.2019.01.013. Epub 2019 Jan 30.

PMID:
30808547
12.

Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.

Hamilton ZA, Capitanio U, Lane BR, Larcher A, Yim K, Dey S, Cotta BH, Meagher MF, Kirmiz S, Bezinque A, Eldefrawy A, Bradshaw A, Ryan S, Carenzi C, Wan F, Proudfoot J, Montorsi F, Derweesh IH.

World J Urol. 2019 Nov;37(11):2429-2437. doi: 10.1007/s00345-019-02650-9. Epub 2019 Feb 1.

PMID:
30710156
13.

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.

Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, Timpson NJ, Haycock PC, Brown KM, Wang Z, Ye Y, Hofmann JN, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Garnier JG, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Radojevic-Skodric S, Ognjanovic S, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Benhamou S, Cancel-Tassin G, Cussenot O, Weiderpass E, Ljungberg B, Tumkur Sitaram R, Häggström C, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Andreotti G, Beane Freeman LE, Koutros S, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Wilson KM, Gaziano JM, Sesso HD, Freedman ND, Parker AS, Eckel-Passow JE, Huang WY, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Lathrop GM, Deleuze JF, Gunter M, McKay JD, Wu X, Houlston RS, Chanock SJ, Relton C, Richards JB, Martin RM, Davey Smith G, Brennan P.

PLoS Med. 2019 Jan 3;16(1):e1002724. doi: 10.1371/journal.pmed.1002724. eCollection 2019 Jan.

14.

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.

Kim HL, Li P, Huang HC, Deheshi S, Marti T, Knudsen B, Abou-Ouf H, Alam R, Lotan TL, Lam LLC, du Plessis M, Davicioni E, Fleshner N, Lane BR, Ross AE, Davis JW, Mohler JL, Trock BJ, Klein EA, Tosoian JJ, Hyndman ME, Bismar TA.

Prostate Cancer Prostatic Dis. 2019 Sep;22(3):399-405. doi: 10.1038/s41391-018-0101-6. Epub 2018 Dec 12.

15.

Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study.

Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G, Sanguedolce F, Brookman-May S, Akdogan B, Capitanio U, Roscigno M, Volpe A, Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, Carini M, Minervini A, Lane BR.

Urol Oncol. 2019 Jan;37(1):33-39. doi: 10.1016/j.urolonc.2018.11.007. Epub 2018 Nov 23.

PMID:
30473205
16.

Computational methods to model complex systems in sports injury research: agent-based modelling (ABM) and systems dynamics (SD) modelling.

Hulme A, Mclean S, Salmon PM, Thompson J, Lane BR, Nielsen RO.

Br J Sports Med. 2019 Dec;53(24):1507-1510. doi: 10.1136/bjsports-2018-100098. Epub 2018 Nov 17. No abstract available.

PMID:
30448782
17.

Evaluation of Urinary Renal Biomarkers for Early Prediction of Acute Kidney Injury Following Partial Nephrectomy: A Feasibility Study.

Lane BR, Babitz SK, Vlasakova K, Wong A, Noyes SL, Boshoven W, Grady P, Zimmerman C, Engerman S, Gebben M, Tanen M, Glaab WE, Sistare FD.

Eur Urol Focus. 2018 Nov 10. pii: S2405-4569(18)30318-3. doi: 10.1016/j.euf.2018.10.017. [Epub ahead of print]

PMID:
30425001
18.

Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.

Kaye DR, Qi J, Morgan TM, Linsell S, Ginsburg KB, Lane BR, Montie JE, Cher ML, Miller DC; Michigan Urological Surgery Improvement Collaborative.

BJU Int. 2019 May;123(5):846-853. doi: 10.1111/bju.14554. Epub 2018 Oct 15.

PMID:
30248225
19.

Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.

Kirmiz S, Qi J, Babitz SK, Linsell S, Denton B, Singh K, Auffenberg G, Montie JE, Lane BR.

J Urol. 2019 Feb;201(2):278-283. doi: 10.1016/j.juro.2018.08.081.

PMID:
30195846
20.

Comparison of RENAL, PADUA, CSA, and PAVP Nephrometry Scores in Predicting Functional Outcomes After Partial Nephrectomy.

Gupta R, Tori M, Babitz SK, Tobert CM, Anema JG, Noyes SL, Lane BR.

Urology. 2019 Feb;124:160-167. doi: 10.1016/j.urology.2018.03.055. Epub 2018 Aug 11.

PMID:
30107186
21.

Open partial nephrectomy when a non-flank approach is required: indications and outcomes.

Caraballo ER, Palacios DA, Suk-Ouichai C, Wu J, Dong W, Tanaka H, Wang Y, Lane BR, Campbell SC.

World J Urol. 2019 Mar;37(3):515-522. doi: 10.1007/s00345-018-2414-4. Epub 2018 Jul 24.

PMID:
30043248
22.

National Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based Algorithms.

Modi PK, Kaufman SR, Qi J, Lane BR, Cher ML, Miller DC, Hollenbeck BK, Shahinian VB, Dupree JM.

Urology. 2018 Oct;120:96-102. doi: 10.1016/j.urology.2018.06.037. Epub 2018 Jul 7.

23.

Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HBA, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2018 Sep;74(3):e85-e86. doi: 10.1016/j.eururo.2018.05.017. Epub 2018 May 28. No abstract available.

PMID:
29853305
24.

Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer.

Kaye DR, Qi J, Morgan TM, Linsell S, Lane BR, Montie JE, Cher ML, Miller DC; Michigan Urological Surgery Improvement Collaborative.

Urology. 2018 Aug;118:127-133. doi: 10.1016/j.urology.2018.04.038. Epub 2018 May 21.

PMID:
29792972
25.

Author Reply.

Davenport MS, Lane BR.

Urology. 2018 Jun;116:142-143. doi: 10.1016/j.urology.2018.02.045. Epub 2018 Apr 30. No abstract available.

PMID:
29724564
26.

Growth spurts of small renal masses correlate with pathology.

Tobert CM, Lane BR.

BJU Int. 2018 May;121(5):678-679. doi: 10.1111/bju.14154. No abstract available.

27.

Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.

Curci NE, Lane BR, Shankar PR, Noyes SL, Moriarity AK, Kubat A, Brede C, Montgomery JS, Auffenberg GB, Miller DC, Montie JE, George AK, Davenport MS.

Urology. 2018 Jun;116:137-143. doi: 10.1016/j.urology.2018.02.043. Epub 2018 Apr 10.

PMID:
29653121
28.

Determination of Prostate Volume: A Comparison of Contemporary Methods.

Bezinque A, Moriarity A, Farrell C, Peabody H, Noyes SL, Lane BR.

Acad Radiol. 2018 Dec;25(12):1582-1587. doi: 10.1016/j.acra.2018.03.014. Epub 2018 Mar 30.

PMID:
29609953
29.

Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study.

Hamilton ZA, Uzzo RG, Larcher A, Lane BR, Ristau B, Capitanio U, Ryan S, Dey S, Correa A, Reddy M, Proudfoot JA, Nasseri R, Yim K, Noyes S, Bindayi A, Montorsi F, Derweesh IH.

World J Urol. 2018 Aug;36(8):1255-1262. doi: 10.1007/s00345-018-2261-3. Epub 2018 Mar 12.

PMID:
29532222
30.

Efficacy and safety of transversus abdominis plane blocks versus thoracic epidural anesthesia in patients undergoing major abdominal oncologic resections: A prospective, randomized controlled trial.

Shaker TM, Carroll JT, Chung MH, Koehler TJ, Lane BR, Wolf AM, Wright GP.

Am J Surg. 2018 Mar;215(3):498-501. doi: 10.1016/j.amjsurg.2017.10.055. Epub 2017 Nov 16.

PMID:
29198854
31.

Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter Analysis.

McDonald ML, Lane BR, Jimenez J, Lee HJ, Yim K, Bindayi A, Hamilton ZA, Field CA, Bloch AS, Dey S, Noyes S, McKay R, Millard F, Rini BI, Campbell SC, Derweesh IH.

Clin Genitourin Cancer. 2018 Apr;16(2):e289-e295. doi: 10.1016/j.clgc.2017.09.007. Epub 2017 Sep 25.

PMID:
29113767
32.

Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study.

Zabor EC, Furberg H, Lee B, Campbell S, Lane BR, Thompson RH, Antonio EC, Noyes SL, Zaid H, Jaimes EA, Russo P.

J Urol. 2018 Apr;199(4):921-926. doi: 10.1016/j.juro.2017.10.027. Epub 2017 Oct 21.

33.

Predictors of Long-Term Survival after Renal Cancer Surgery.

Zabell J, Demirjian S, Lane BR, Derweesh IH, Isharwal S, Suk-Ouichai C, Wu J, Palacios DA, Campbell SC.

J Urol. 2018 Feb;199(2):384-392. doi: 10.1016/j.juro.2017.08.096. Epub 2017 Aug 30.

PMID:
28859893
34.

Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery.

Wu J, Suk-Ouichai C, Dong W, Antonio EC, Derweesh IH, Lane BR, Demirjian S, Li J, Campbell SC.

BJU Int. 2018 Jan;121(1):93-100. doi: 10.1111/bju.13994. Epub 2017 Sep 10.

35.

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.

Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HB, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP.

Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7. Erratum in: Eur Urol. 2018 May 28;:.

36.

A Roadmap for Improving the Management of Favorable Risk Prostate Cancer.

Auffenberg GB, Lane BR, Linsell S, Brachulis A, Ye Z, Rakic N, Montie J, Miller DC, Cher ML.

J Urol. 2017 Dec;198(6):1220-1222. doi: 10.1016/j.juro.2017.07.085. Epub 2017 Aug 3. No abstract available.

PMID:
28782516
37.

Holding Strength of a Hem-o-lok/Lapra-Ty Clip Combination on Sutures Used During Partial Nephrectomy.

Paka B, Bossemeyer R, Tourojman M, Gupta R, Lane BR.

Urology. 2017 Sep;107:138-143. doi: 10.1016/j.urology.2017.06.024. Epub 2017 Jun 23.

PMID:
28652162
38.

Practice- vs Physician-Level Variation in Use of Active Surveillance for Men With Low-Risk Prostate Cancer: Implications for Collaborative Quality Improvement.

Auffenberg GB, Lane BR, Linsell S, Cher ML, Miller DC.

JAMA Surg. 2017 Oct 1;152(10):978-980. doi: 10.1001/jamasurg.2017.1586. No abstract available.

39.

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Mark Lathrop G, Rothman N, Deleuze JF, McKay JD, Parker AS, Wu X, Houlston RS, Brennan P, Chanock SJ.

Nat Commun. 2017 Jun 9;8:15724. doi: 10.1038/ncomms15724.

40.

Renal Mass and Localized Renal Cancer: AUA Guideline.

Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervais DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM.

J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4.

PMID:
28479239
41.

Consumer and carer perspectives in the development of a mental health research, treatment and teaching facility: A thematic analysis.

Katsikitis M, Lane BR, Ozols I, Statham D.

J Psychiatr Ment Health Nurs. 2017 Sep;24(7):534-544. doi: 10.1111/jpm.12394. Epub 2017 Jun 29.

PMID:
28449291
42.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW.

Cancer. 2017 Aug 1;123(15):2850-2859. doi: 10.1002/cncr.30665. Epub 2017 Apr 19.

43.

Neoadjuvant Targeted Molecular Therapy Before Renal Surgery.

Dey S, Peabody HN, Noyes SL, Lane BR.

Urol Clin North Am. 2017 May;44(2):289-303. doi: 10.1016/j.ucl.2016.12.014. Epub 2017 Mar 14. Review.

PMID:
28411920
44.

Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature.

Telang JM, Lane BR, Cher ML, Miller DC, Dupree JM.

BJU Int. 2017 Oct;120(4):464-467. doi: 10.1111/bju.13862. Epub 2017 May 3. Review.

45.

Chronic Kidney Disease Is More Common in Locally Advanced Renal Cell Carcinoma.

Dey S, Hamilton Z, Noyes SL, Tobert CM, Keeley J, Derweesh IH, Lane BR.

Urology. 2017 Jul;105:101-107. doi: 10.1016/j.urology.2017.03.033. Epub 2017 Mar 30.

PMID:
28365357
46.

The effects of priming in a cued dot-probe task on appearance-related attentional biases in women.

Lane BR, Mulgrew KE, Mahar D, White MJ, Loughnan SA.

Int J Eat Disord. 2017 Jul;50(7):817-825. doi: 10.1002/eat.22699. Epub 2017 Mar 2.

PMID:
28252801
47.

Prevalence of Proteinuria and Other Abnormalities in Urinalysis Performed in the Urology Clinic.

Bezinque A, Noyes SL, Kirmiz S, Parker J, Dey S, Kahnoski RJ, Lane BR.

Urology. 2017 May;103:34-38. doi: 10.1016/j.urology.2017.02.011. Epub 2017 Feb 14.

PMID:
28212852
48.

Calculating life expectancy to inform prostate cancer screening and treatment decisions.

Hawken SR, Auffenberg GB, Miller DC, Lane BR, Cher ML, Abdollah F, Cho H, Ghani KR; Michigan Urological Surgery Improvement Collaborative.

BJU Int. 2017 Jul;120(1):9-11. doi: 10.1111/bju.13812. Epub 2017 Mar 10. No abstract available.

49.

Collaborative Review of Risk Benefit Trade-offs Between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses.

Kim SP, Campbell SC, Gill I, Lane BR, Van Poppel H, Smaldone MC, Volpe A, Kutikov A.

Eur Urol. 2017 Jul;72(1):64-75. doi: 10.1016/j.eururo.2016.11.038. Epub 2016 Dec 14. Review.

PMID:
27988238
50.

Editorial Comment.

Peabody H, Lane BR, Lane BR.

J Urol. 2017 Mar;197(3 Pt 1):573. doi: 10.1016/j.juro.2016.10.117. Epub 2016 Nov 17. No abstract available.

PMID:
27865906

Supplemental Content

Support Center